M
Miho Murata
Researcher at University of Tokyo
Publications - 116
Citations - 6025
Miho Murata is an academic researcher from University of Tokyo. The author has contributed to research in topics: Parkinson's disease & Parkinsonism. The author has an hindex of 34, co-authored 115 publications receiving 5371 citations.
Papers
More filters
Journal ArticleDOI
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
Wataru Satake,Yuko Nakabayashi,Yuko Nakabayashi,Ikuko Mizuta,Ikuko Mizuta,Yushi Hirota,Yushi Hirota,Chiyomi Ito,Chiyomi Ito,Michiaki Kubo,Takahisa Kawaguchi,Tatsuhiko Tsunoda,Masahiko Watanabe,Atsushi Takeda,Hiroyuki Tomiyama,Kenji Nakashima,Kazuko Hasegawa,Fumiya Obata,Takeo Yoshikawa,Hideshi Kawakami,Saburo Sakoda,Mitsutoshi Yamamoto,Nobutaka Hattori,Miho Murata,Yusuke Nakamura,Tatsushi Toda,Tatsushi Toda +26 more
TL;DR: The results identify two new PD susceptibility loci, show involvement of autosomal dominant parkinsonism loci in typical PD and suggest that population differences contribute to genetic heterogeneity in PD.
Journal ArticleDOI
O1-7-4-1Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
Wataru Satake,Ikuko Mizuta,Michiaki Kubo,Takahisa Kawaguchi,Tatsuhiko Tsunoda,Takeo Yoshikawa,Saburo Sakoda,Mitsutoshi Yamamoto,Nobutaka Hattori,Miho Murata,Yusuke Nakamura,Tatsushi Toda +11 more
TL;DR: Clinical and genetic information of 5 Japanese patients with Bardet-Biedl syndrome is summarized and it is found that rare liver fibrosis was detected in two patients, while only two patients had renal dysfunction, thought to be a universal symptom.
Journal ArticleDOI
Clinical heterogeneity of α‐synuclein gene duplication in Parkinson's disease
Kenya Nishioka,Shin Hayashi,Matthew J. Farrer,Andrew B. Singleton,Hiroyo Yoshino,Hisamasa Imai,Toshiaki Kitami,Kenichi Sato,Ryu Kuroda,Hiroyuki Tomiyama,Koichi Mizoguchi,Miho Murata,Tatsushi Toda,Issei Imoto,Johji Inazawa,Yoshikuni Mizuno,Nobutaka Hattori +16 more
TL;DR: The objective of this study was to assess the frequency of SNCA multiplications among autosomal dominant hereditary Parkinson's disease (ADPD) patients.
Journal ArticleDOI
Efficacy of the anti–IL-6 receptor antibody tocilizumab in neuromyelitis optica A pilot study
Manabu Araki,Takako Matsuoka,Katsuichi Miyamoto,Susumu Kusunoki,Tomoko Okamoto,Miho Murata,Sachiko Miyake,Toshimasa Aranami,Takashi Yamamura +8 more
TL;DR: This study provides Class IV evidence that in patients with NMO, TCZ reduces relapse rate, neuropathic pain, and fatigue, and Class III evidence that Interleukin-6 receptor blockade is a promising therapeutic option for NMO.
Journal ArticleDOI
Zonisamide improves motor function in Parkinson disease: A randomized, double-blind study
TL;DR: Zonisamide is safe, effective and well tolerated at 25 to 100 mg/day as an adjunctive treatment in patients with Parkinson disease.